Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester.

Xu, Danping; Zhu, Yiyang; Li, Lanfang; Xu, Yingping; Yan, Weihua; Dai, Meizhen; Gan, Linghong

Xu, Danping; Zhu, Yiyang; Li, Lanfang; Xu, Yingping; Yan, Weihua; Dai, Meizhen; Gan, Linghong.

Afiliación

Xu D; Reproductive Center, Taizhou Hospital of Zhejiang Province, Wezhou Medical University, Wenzhou, China.
Zhu Y; Reproductive Center, Taizhou Hospital of Zhejiang Province, Wezhou Medical University, Wenzhou, China.
Li L; Reproductive Center, Taizhou Hospital of Zhejiang Province, Wezhou Medical University, Wenzhou, China.
Xu Y; Reproductive Center, Taizhou Hospital of Zhejiang Province, Wezhou Medical University, Wenzhou, China.
Yan W; Medical Research Center, Taizhou Hospital of Zhejiang Province, Wezhou Medical University, Wenzhou, China.
Dai M; Medical Research Center, Taizhou Hospital of Zhejiang Province, Wezhou Medical University, Wenzhou, China.
Gan L; Medical Research Center, Taizhou Hospital of Zhejiang Province, Wezhou Medical University, Wenzhou, China.

Front Genet ; 11: 497264, 2020.

Article en En | MEDLINE | ID: mdl-33574829

Palabras clave

chromsome; fetus; human leukocyte antigen-G; pregnancy; soluble HLA-G; trisomy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Genet Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google